ASCO Guidelines

175 Episodes

1. Testing for ESR1 Mutations to Guide Therapy for HR-Positive, HER2-Negative Metastatic Breast Cancer Rapid Recommendation Update

   Published: 5/17/2023
2. VTE Prophylaxis and Treatment in Patients with Cancer Guideline Update

   Published: 4/19/2023
3. Management of Anxiety and Depression in Adult Survivors of Cancer Guideline Update

   Published: 4/19/2023
4. Therapy for Stage IV NSCLC With Driver Alterations: ASCO Living Guideline Update 2023.1 Part 2

   Published: 4/6/2023
5. Therapy for Stage IV NSCLC Without Driver Alterations: ASCO Living Guideline Update 2023.1 Part 1

   Published: 4/6/2023
6. Initial Management of Noncastrate Advanced, Recurrent, or Metastatic Prostate Cancer Guideline Update

   Published: 4/3/2023
7. Penile Cancer: EAU-ASCO Guideline

   Published: 3/10/2023
8. Chemotherapy and Targeted Therapy for Endocrine-Pretreated or Hormone Receptor–Negative Metastatic Breast Cancer Rapid Recommendation Update

   Published: 1/20/2023
9. Mismatch Repair and Microsatellite Instability Testing for Immune Checkpoint Inhibitor Therapy: ASCO Endorsement of CAP Guideline

   Published: 1/6/2023
10. Targeted Therapy and Immunotherapy for Gastroesophageal Cancer Guideline

    Published: 1/5/2023
11. Therapy for Stage IV NSCLC With Driver Alterations: ASCO Living Guideline Update 2022.2 Part 2

    Published: 12/19/2022
12. Therapy for Stage IV NSCLC Without Driver Alterations: ASCO Living Guideline Update 2022.2 Part 1

    Published: 12/19/2022
13. Immunotherapy and Biomarker Testing in Recurrent and Metastatic Head and Neck Cancers Guideline

    Published: 12/15/2022
14. Use of Opioids for Adults with Pain from Cancer or Cancer Treatment Guideline

    Published: 12/5/2022
15. Treatment of Metastatic Colorectal Cancer Guideline

    Published: 10/17/2022
16. PARP Inhibitors in the Management of Ovarian Cancer Rapid Recommendation Update

    Published: 10/3/2022
17. Secondary Prevention of Cervical Cancer Resource-Stratified Guideline Update

    Published: 9/26/2022
18. Systemic Therapy Update on 177Lutetium-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer: ASCO Rapid Recommendation Update

    Published: 9/21/2022
19. Integrative Medicine for Pain Management in Oncology: SIO-ASCO Guideline

    Published: 9/19/2022
20. Chemotherapy and Targeted Therapy for HER2-Negative Metastatic Breast Cancer that is Either Endocrine-Pretreated or Hormone Receptor–Negative: ASCO Guideline Rapid Recommendation Update

    Published: 8/4/2022